Genentech sues Biogen for debt over blockbuster MS drug

Published Date: 08 Mar 2023

Roche's Genentech Inc sued Biogen MA Inc in federal court in San Francisco, alleging that Biogen owed additional patent royalties from worldwide sales of its blockbuster multiple sclerosis and Crohn's disease drug, Tysabri.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer

2.

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

3.

Getting More Done With Less Blood.

4.

Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.

5.

Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot